Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
Introduction Memantine is a noncompetitive N-methyl-D-aspartate receptor antagonist approved by the FDA for moderate to severe Alzheimer’s dementia. Memantine is also recommended as an off-label treatment in current catatonia clinical guidelines when benzodiazepines alone are inadequate. Case A 37-y...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Association of Psychiatric Pharmacists
2025-08-01
|
| coleção: | Mental Health Clinician |
| Assuntos: | |
| Acesso em linha: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.08.218 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|